China INSOnline Corp. to Aggressively Combat Naked Short Sales of Company’s Common Stock
PRNewswire, 01 June 2010
China INSOnline Corp. (Nasdaq: CHIO), which operates http://www.soobao.cn , one of China’s leading insurance services web portals, today declares its intention to aggressively combat naked short selling of the Company’s common stock and protect its shareholder’s interests. This is expected to improve stability in the value of its stock and improve long-term investor confidence in the market.
Today the company’s suspicions were confirmed when NASDAQ OMX published the results on the short list under the regulation SHO Threshold Security List. Continue reading “Article: China INSOnline Corp. to Aggressively Combat Naked Short Sales of Company’s Common Stock”
Overstock.com Congratulates Bloomberg Television for Its Emmy Nomination for ‘Phantom Shares’, a Special Report on Naked Short Selling
PRNewswire, 02 November 2007
Bloomberg Television’s special report on naked short selling entitled “Phantom Shares” was nominated for an Emmy(R) Award for Business & Financial Reporting by the National Academy of Television Arts & Sciences. The report, which was nominated for outstanding investigative reporting of a business news story – news magazines and long form, featured Overstock.com and its Chairman and CEO, Patrick Byrne, extensively. It examined the strategy and execution of naked short selling, the threat this poses to American entrepreneurship, and the steps regulators are taking to control it.
Patrick Byrne said of the news, “Unsettled trades in our stock settlement system present a serious problem to our capital markets. Bloomberg’s report shed light on the issue and brought it into the mainstream. It is an example of the critical, investigative mindset that is essentially absent within American financial journalism, and I am pleased to see Bloomberg being recognized for its fine work.”
Read Full Article
Bionano Genomics : SEC Filing (424B3) – Supplemental Prospectus
MarketScreener, 20 March 2020
This prospectus covers the offer and resale by Innovatus Life Sciences Lending Fund I, LP, or Innovatus, and Innovatus Life Sciences Offshore Fund I-A, LP, or Innovatus Offshore, of up to an aggregate of 1,141,408 shares of our common stock, which includes 161,987 shares of our common stock issuable upon the exercise of warrants, issued to Innovatus and Innovatus Offshore in private transactions. Innovatus and Innovatus Offshore are also collectively referred to in this prospectus as the selling stockholders.
We are not selling any shares of common stock under this prospectus and will not receive any of the proceeds from the sale by the selling stockholders of such shares. Continue reading “Article: Bionano Genomics : SEC Filing (424B3) – Supplemental Prospectus”